Central Trust Company’s PetMed Express PETS Stock Holding History

Central Trust Company’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-525	Closed	-$9.29K	–	1293
2022 Q4	$9.29K	Hold	525	–	–	﹤0.01%	1020
2022 Q3	$10K	Hold	525	–	–	﹤0.01%	1041
2022 Q2	$10K	Hold	525	–	–	﹤0.01%	1047
2022 Q1	$14K	Hold	525	–	–	﹤0.01%	1025
2021 Q4	$13K	Hold	525	–	–	﹤0.01%	1023
2021 Q3	$14K	Hold	525	–	–	﹤0.01%	983
2021 Q2	$17K	Hold	525	–	–	﹤0.01%	912
2021 Q1	$18K	Hold	525	–	–	﹤0.01%	853
2020 Q4	$17K	Hold	525	–	–	﹤0.01%	829
2020 Q3	$17K	Hold	525	–	–	﹤0.01%	790
2020 Q2	$19K	Buy	525 +225	+75%	+$7.81K	﹤0.01%	746
2020 Q1	$9K	Buy	+300	New	+$7.86K	﹤0.01%	883
2017 Q3	–	Sell	-100	Closed	-$4K	–	1326
2017 Q2	$4K	Buy	+100	New	+$3.1K	﹤0.01%	1086

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Central Trust Company's PETS Position: Q1 2023 in Review

Central Trust Company sold out of PetMed Express (PETS) in Q1 2023, closing a stake of 525 shares — an estimated $9.29K sold.

Central Trust Company first reported a position in PETS in Q2 2017 and held it in 13 quarters. The position peaked at $19K in Q2 2020. 165 funds tracked by Wall St. Rank hold PETS as of Q1 2023.

Central Trust Company reported no remaining PetMed Express position as of Q1 2023 after selling out during the quarter.
Central Trust Company sold 525 PetMed Express shares in Q1 2023, an estimated $9.29K.
Central Trust Company first reported a position in PetMed Express in Q2 2017 and held it in 13 quarters.
Central Trust Company's PetMed Express position peaked at $19K in Q2 2020.
165 funds tracked by Wall St. Rank held PetMed Express as of Q1 2023.

Based on Central Trust Company's 13F filing for Q1 2023, filed 19 Apr 2023.